Studies of Monoamine Oxidase and Semicarbazide-Sensitive Amine Oxidase: I. Inhibition by a Selective Monoamine Oxidase-B Inhibitor, MD 780236

Abstract

AbstractIn vitro studies of the effect of MD 780236, a selective monoamine oxidase (MAO)-B inhibitor, on a semicarbazide-sensitive amine oxidase (SSAO) in rat testis and lung showed that this compound dose-dependency inhibited SSAO activity. The extents of inhibition of MAO-A, -B and SSAO in these two rat tissues by this compound after 30 mm of preincubation were found to be MAO-B>MAO-A>SSAO. This selectivity was also evident in preparations without preincubation. Degree of inhibition of SSAO was not significantly influenced by pretreatment with either 10−3M clorgyline, l-deprenyl or 10−4 M SKF 525A. Inhibition of SSAO was not enhanced by varying the time of preincubation of the enzyme and the compound, indicating direct action on and reversible inhibition of SSAO. The inhibition of SSAO by MD 780236 was non-competitive with or without preincubation, with a K1 value of 110 μM. Although MD 780236 is a selective and “suicide substrate” inhibitor of MAO-B. these present results indicate that this compound may also inhibit SSAO activity, but by a mechanism different from that for MAO-B. These findings confirm an earlier hypothesis that compounds that inhibit both MAO and SSAO have totally different modes of action on these two different amine oxidases.